ascopubs.org

Outcome with total therapy 3 (TT3) compared to total therapy 2 (TT2): Role of GEP70-defined high-risk disease with trisomy of 1q21 and activation of the proteasome gene PSMD4.

Comparison of bortezomib- and lenalidomide-based therapies for the treatment of primary (AL) amyloidosis. Background: A GEP-based risk model (GEP70) defines 15% of newly diagnosed MM with a median ...
ascopubs.org

Genomic evolution in total therapy 2 (TT2) and total therapy 3 (TT3) for newly diagnosed multiple myeloma (MM): Comparison of baseline (BL) and relapse (REL) gene expression ...

Cure fractions (CF) modeled from event-free survival and complete response duration plots in total therapy (TT) trials for newly diagnosed multiple myeloma (MM). Background: Little is known about the ...
Nature

Improvement in long-term outcomes with successive Total Therapy trials for multiple myeloma: are patients now being cured?

The details of trial design and dosing were reported previously for TT1, TT2 and TT3(refs 4, 5, 6, 7) and are briefly described here. All three protocols used ...
EurekAlert!

Proposed model for TT3.1 and TT3.2 function in thermotolerance (IMAGE)

Dubbed thermotolerance 3, or TT3, the genetic module is the physical location in the cell’s genetic material containing the genes, TT3.1 and TT3.2, that interact to enhance rice thermotolerance. News ...